CATEGORY

Breaking

Gen Z Considers Hamas ‘Freedom Fighters,’ Poll Shows

A poll from the British group More in Common found that Gen Z is as likely to consider Hamas "freedom fighters" as they are to call them "terrorists."

One-Third of Palestinian Deaths in Gaza are Due to Hamas

One-third of the reported Palestinians deaths in Gaza are reportedly due to Hamas terrorists, according to an off-the-record briefing by the Israel Defense Forces (IDF) for foreign journalists.

Large Group of Young Men From China Invade U.S. Border

A large group of military-age men from China invaded the southern border in California this week.

University of Utah Professors Cancel Classes To Host ‘Healing Circles’ After Detransitioner’s Speech on Campus

Some professors at the University of Utah have cancelled classes to host "healing circles" over an upcoming speech on campus featuring a woman who detransitioned at 16.

Air Force Studies Cancers for Service Members Who Worked With Nuclear Weapons

The Air Force is conducting a study on the correlation between service members who have worked with nuclear missiles in the past and the high rate of cancer.

Biden Admin to Spend $3 Billion to Address International Climate Change

Vice President Kamala Harris announced at the United Nations' annual climate summit that the U.S. will spend $3 billion to address climate change overseas.

Biden Impeachment Inquiry a ‘Necessary Step’: Speaker Johnson

House Speaker Mike Johnson (R-LA) said during a Fox News interview that an impeachment inquiry into President Joe Biden is a "necessary step."

Islamic Terrorists Bomb Catholic Mass in Philippines

Suspected Islamic terrorists bombed a Catholic Mass in the Philippines over the weekend, killing at least four in attendance.

High School in West Virginia Approves Student-Led Bible Study Club

A West Virginia high school is implementing a morning Bible study club available to students.

Pfizer Halts Weight Loss Pill After Study Shows ‘High Rates’ of Adverse Side Effects

Pfizer announced last week that it is discontinuing development of its twice-daily weight loss pill "danuglipron" after a clinical trial showed "high rates" of adverse side effects among users.

Latest news

- Advertisement -spot_img